Advertisement

RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 878)

Abstract

The retinoid acid receptor-β (RARβ) gene is one of the tumor suppressor genes (TSGs), which is frequently deleted or epigenetically silenced at an early stage of tumor progression. In this study we investigated the promoter methylation and expression status of the RARß gene in 60 surgically resected non-small cell lung cancer (NSCLC) tissue samples and 60 corresponding unchanged lung tissue samples, using methylation-specific PCR and real-time-polymerase chain reaction (qPCR) techniques. We correlated the results with the pathological features of tumors and clinical characteristics of patients. qPCR analysis detected a significantly lower RARß expression in the patients with adenocarcinoma (AC) and large cell carcinoma (LCC) than in those with squamous cell carcinoma (SCC) (AC vs. SCC, p = 0.032; AC and LCC vs. SCC, p = 0.013). Additionally, significantly lower expression of the RARß gene was revealed in the patients with non-squamous cell cancer with a history of smoking assessed as pack-years (PY <40 vs. PY ≥40, p = 0.045). Regarding RARß promoter methylation, we found significant differences in the methylation index in the SCC group when considering pTNM staging; with higher index values in T1a + T1b compared with T2a + T2b and T3 + T4 groups (p = 0.024). There was no correlation between the methylation status and expression level of the RARß gene, which suggests that other molecular mechanisms influence the RARß expression in NSCLC patients. In conclusion, different expression of the RARß gene in SCC and NSCC makes the RARß gene a valuable diagnostic marker for differentiating the NSCLC subtypes.

Keywords

Gene expression Lung cancer NSCLC Promoter methylation Retinoid acid receptor-β gene Smoking Tumor suppressor gene 

Notes

Acknowledgements

This work was supported by a grant for young scientists of Medical University of Lodz no. 502-03/1-151-03/502-14-142.

Conflicts of Interest

The authors have no conflicts of interest concerning this study.

References

  1. Agudo A, Bonet C, Travier N, González CA, Vineis P, Bueno-de-Mesquita HB, Trichopoulos D et al (2012) Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol 30:4550–4557CrossRefPubMedGoogle Scholar
  2. AJCC – American Joint Committee on Cancer Staging according to the IASCLC Staging Project (2010) 7th edn, CancerGoogle Scholar
  3. Bhagat R, Kumar SS, Vaderhobli S, Premalata CS, Pallavi VR, Ramesh G, Krishnamoorthy L (2014) Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma. Tumour Biol 35(9):9069–9078CrossRefPubMedGoogle Scholar
  4. Brabender J, Metzger R, Salonga D, Danenberg KD, Danenberg PV, Hölscher AH, Schneider PM (2005) Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer implications for tumor development and prognosis. Carcinogenesis 26(3):525–530CrossRefPubMedGoogle Scholar
  5. Eissa S, Zohny SF, Shehata HH, Hegazy MG, Salem AM, Esmat M (2012) Urinary retinoic acid receptor-ß2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer. Clin Biochem 45(6):402–407CrossRefPubMedGoogle Scholar
  6. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR et al (2010) Non-small cell lung cancer. J Natl Compr Cancer Netw 8(7):740–801Google Scholar
  7. Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM (2003) Predicting aberrant CpG island methylation. Proc Natl Acad Sci U S A 100:12253–12258PubMedCentralCrossRefPubMedGoogle Scholar
  8. Gao T, He B, Pan Y, Li R, Xu Y, Chen L, Nie Z, Gu L, Wang S (2013) The association of retinoic acid receptor beta2 (RARß2) methylation status and prostate cancer risk: a systematic review and meta-analysis. PLoS One 8(5):e62950PubMedCentralCrossRefPubMedGoogle Scholar
  9. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L, International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714CrossRefPubMedGoogle Scholar
  10. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics. CA Cancer J Clin 50:7–33CrossRefPubMedGoogle Scholar
  11. Khodyrev DS, Pronina IV, Rykov SV, Beresneva EV, Fridman MV, Kazubskaia TP, Loginov VI, Braga ÉA (2012) Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer. Mol Biol (Mosk) 46(5):773–785CrossRefGoogle Scholar
  12. Li W, Deng J, Jiang P, Zeng X, Hu S, Tang J (2012) Methylation of the RASSF1A and RARß genes as a candidate biomarker for lung cancer. Exp Ther Med 3(6):1067–1071PubMedCentralPubMedGoogle Scholar
  13. Liu Z, Zhao J, Chen XF, Li W, Liu R, Lei Z, Liu X, Peng X, Xu K, Chen J, Liu H, Zhou QH, Zhang HT (2008) CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Lung Cancer 62(1):15–22CrossRefPubMedGoogle Scholar
  14. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS (2010) Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29(25):3650–3664CrossRefPubMedGoogle Scholar
  15. Nervi C, Grignani F (2014) RARs and microRNAs. Subcell Biochem 70:151–179CrossRefPubMedGoogle Scholar
  16. Pastuszak-Lewandoska D, Czarnecka KH, Migdalska-Sęk M, Nawrot E, Domańska D, Kiszałkiewicz J, Kordiak J, Antczak A, Górski P, Brzeziańska-Lasota E (2015) Decreased FAM107A expression in patients with non-small cell lung cancer. Adv Exp Med Biol 11:39–48Google Scholar
  17. Picard E, Seguin C, Monhoven N, Rochette-Egly C, Siat J, Borrelly J, Martinet Y, Martinet N, Vignaud JM (1999) Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 91(12):1059–1066CrossRefPubMedGoogle Scholar
  18. Sasco AJ, Secretan MB, Straif K (2004) Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45(Suppl 2):3–9CrossRefGoogle Scholar
  19. Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K (2012) Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Mutagenesis 27(4):423–429CrossRefPubMedGoogle Scholar
  20. Sirchia SM, Ren M, Pili R (2002) Endogenous reactivation of the RARß2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 62:2455–2461PubMedGoogle Scholar
  21. Souto-Garcia A, Fernández-Somoano A, Pascual T, Álvarez-Avellón SM, Tardón A (2012) Association of p21 Ser31Arg and p53Arg77Pro polymorphisms with lung cancer risk in CAPUA study. Lung Cancer Targets Ther 3:69–78CrossRefGoogle Scholar
  22. Staaf J, Isaksson S, Karlsson A, Jönsson M, Johansson L, Jönsson P, Botling J, Micke P, Baldetorp B, Planck M (2013) Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Int J Cancer 132(9):2020–2031CrossRefPubMedGoogle Scholar
  23. Tan C, Jin YT, Xu HY, Zhang CY, Zhang H, Zhang WM, Chen CM, Sun XY (2012) Correlation between RARbeta gene promoter methylation and P53 gene mutations in non-small cell lung cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29(2):131–136PubMedGoogle Scholar
  24. Virmani AK, Rathi A, Zochbauer-Muller S (2000) Promoter methylation and silencing of the retinoic acid receptor- beta gene in lung carcinomas. J Natl Cancer Inst (Bethesda) 92:1303–1307CrossRefGoogle Scholar
  25. Word B, Lyn-Cook LE, Mwamba B, Wang H, Lyn-Cook B, Hammons G (2013) Cigarette smoke condensate induces differential expression and promoter methylation profiles of critical genes involved in lung cancer in NL-20 lung cells in vitro: short-term and chronic exposure. Int J Toxicol 32(1):23–31CrossRefPubMedGoogle Scholar
  26. Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, Wang J, Chen L (2011) Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett 303(1):21–28CrossRefPubMedGoogle Scholar
  27. Zhao Y, Zhou H, Ma K, Sun J, Feng X, Geng J, Gu J, Wang W, Zhang H, He Y, Guo S, Zhou X, Yu J, Lin Q (2013) Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer. Oncol Lett 5(4):1211–1218PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of General and Oncological PulmonologyMedical University of LodzLodzPoland
  2. 2.Department of Molecular Bases of MedicineMedical University of LodzLodzPoland
  3. 3.Department of Pneumology and Allergy, First Chair of Internal DiseasesMedical University of LodzLodzPoland
  4. 4.Department of Chest Surgery, General and Oncological Surgery University Hospital No. 2Medical University of LodzLodzPoland

Personalised recommendations